Autem Therapeutics develops bioelectric technologies that utilize targeted electrical stimulation to enhance the effectiveness of cancer therapies. By increasing tumor responsiveness to treatments, the company aims to improve patient outcomes while reducing the associated side effects.
Funding
$13.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Existing cancer therapies often face challenges in effectively targeting and eradicating cancer cells, leading to suboptimal patient outcomes and significant side effects. Cancer cells' metabolic cycles are often desynchronized from healthy cells, causing disproportionate energy usage and energy deprivation in nearby healthy cells.
Solution
Autem Therapeutics is developing AutEMsysTM, a bioelectric technology that uses low-level, amplitude-modulated electromagnetic (EM) frequencies to re-synchronize the electrophysiological properties of cancer cells, increasing their responsiveness to existing treatments. By delivering targeted electrical stimulation, the therapy aims to balance the energy of cancer cells, making them more susceptible to conventional cancer treatments. The AutEMsysTM is designed to be accessible, treating up to 40 patients per month without requiring refrigeration or sophisticated infrastructure, potentially improving treatment accessibility in remote areas. The company's patent-protected approach seeks to improve patient outcomes while reducing the side effects associated with traditional cancer therapies.
Target Audience
The primary target audience includes cancer patients undergoing treatment and healthcare providers seeking to enhance the effectiveness and accessibility of cancer therapies.
Features
- Low-level, amplitude-modulated electromagnetic (EM) frequency delivery
- Designed to re-synchronize cancer cells' electrophysiological properties
- Non-invasive application
- Can treat up to 40 patients per month
- Does not require refrigeration
- Designed for accessibility in remote areas